Zobrazeno 1 - 10
of 96
pro vyhledávání: '"JL Fuster"'
Autor:
Adela Cañete, Rafael Peris-Bonet, Riccardo Capocaccia, Elena Pardo-Romaguera, Vanessa Segura, Ana Muñoz-López, Ana Fernández-Teijeiro, Jaume Galceran-Padros, Gemma Gatta, F Almazán, AI Benito, MI Buedo, C Calvo, A Cañete, O Cruz, C Esquembre, M Fernández, A Fernández-Teijeiro Álvarez, JL Fuster, M García, C Gil López, J Gómez, A Gondra, M González, H González, B Herrero, A Lassaletta, R López, B López-Ibor Aliño, L Madero, S Maldonado, FJ Mares, C Márquez, ME Mateos, K Melwani, MC Mendoza, L Moreno, ML Moreno, GM Muñoz, MJ Ortega, E Panizo, S Pisa Gatell, R Portugal, M Sagaseta, JA Salinas, A Sastre, M Tallón, M Torrent, JJ Uriz, A Varo, MA Vázquez, JS Vílchez, JA Villegas, JL Vivanco, M Zamora, R Alamo, A Alemán, M Chico, MD Chirlaque, J Galceran, R Marcos, A Mateos, JR Quirós, C Sanchez-Contador, C Sabater
Publikováno v:
Cancer Epidemiology. 78:102145
Linkage between clinical databases and population-based cancer registries may serve to evaluate European Reference Networks' (ERNs) activity, by monitoring the proportion of patients benefiting from these and their impact on survival at a population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50bd5b5e6989dd25bf3514796c7f251d
https://doi.org/10.1016/j.canep.2022.102145
https://doi.org/10.1016/j.canep.2022.102145
Autor:
Sisinni L; Hematología y Oncología Pediátrica, Hospital Universitario La Paz, Madrid. Electronic address: sisinniluisa@gmail.com., Monserrate GXA; Servicio de Hematología, Hospital Clínico Universitario de Valladolid, Valladolid., Hurtado JMP; Unidad de Hematología Pediátrica, UGC Hematología, Hospital Virgen del Rocío, Sevilla., Panesso M; Servicio de Oncología y Hematología Pediátrica, Unidad HSCT. Hospital Universitari Vall d'Hebron, Barcelona., Molina B; Hematología-Oncología Pediátrica, Hospital Niño Jesús, Madrid., Fuentes C; Hematologia Pediátrica, Hospital La Fe, Valencia., Fuster JL; Sección de Oncohematología Pediátrica, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia., Verdu-Amoros J; Hematología Pediátrica, Hospital Clínico Universitario; INCLIVA-Biomedical Research Institute, Valencia., Regueiro A; Hematologia pediátrica, Hospital Santiago de Compostela., Palomo P; Hematología Pediátrica, Hospital Universitario Central de Asturia, Oviedo., Beléndez C; Hematología Pediátrica, Hospital Gregorio Marañon, Madrid., Pascual A; Hematología pediátrica, Hospital de Malaga., Badell I; Hematología-Oncología Pediátrica, Hospital Santa Creu i Sant Pau, Barcelona, Spain., Mozo Y; Hematología y Oncología Pediátrica, Hospital Universitario La Paz, Madrid., Bueno D; Hematología y Oncología Pediátrica, Hospital Universitario La Paz, Madrid., Pérez-Martínez A; Hematología y Oncología Pediátrica, Hospital Universitario La Paz, Madrid., Fernández JM; Hematologia Pediátrica, Hospital La Fe, Valencia., Vicent MG; Hematología-Oncología Pediátrica, Hospital Niño Jesús, Madrid., de Heredia CD; Servicio de Oncología y Hematología Pediátrica, Unidad HSCT. Hospital Universitari Vall d'Hebron, Barcelona.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2024 Oct; Vol. 30 (10), pp. 1015.e1-1015.e13. Date of Electronic Publication: 2024 Jul 25.
Autor:
Juan-Ribelles A; Pediatric Oncology and Hematology Unit, Hospital Universitari y Politécnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain., Bautista F; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Cañete A; Pediatric Oncology and Hematology Unit, Hospital Universitari y Politécnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain., Rubio-San-Simón A; Pediatric Oncology, Hematology and Stem Cell Transplant Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain., Alonso-Saladrigues A; Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu, Institut de Recerca San Joan de Déu (IRSJD), Barcelona, Spain., Hladun R; Division of Pediatric Hematology and Oncology, Vall d'Hebron Comprehensive Cancer Center, Hospital Universitari Vall d'Hebrón, Passeig Vall d'Hebron 119, 08172, Barcelona, Spain., Rives S; Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu, Institut de Recerca San Joan de Déu (IRSJD), Barcelona, Spain., Dapena JL; Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu, Institut de Recerca San Joan de Déu (IRSJD), Barcelona, Spain., Fernández JM; Pediatric Oncology and Hematology Unit, Hospital Universitari y Politécnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain., Lassaletta Á; Pediatric Oncology, Hematology and Stem Cell Transplant Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain., Cruz O; Pediatric Cancer Center Barcelona (PCCB), Hospital Sant Joan de Déu, Institut de Recerca San Joan de Déu (IRSJD), Barcelona, Spain., Ramírez-Villar G; Department of Pediatric Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain., Fuster JL; Hospital Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain., de Heredia CD; Division of Pediatric Hematology and Oncology, Vall d'Hebron Comprehensive Cancer Center, Hospital Universitari Vall d'Hebrón, Passeig Vall d'Hebron 119, 08172, Barcelona, Spain., García-Ariza M; Biocruces Bizkaia Health Research Institute, Hospital Universitario Cruces, Osakidetza, Barakaldo, Bizkaia, Spain., Quiroga E; Department of Pediatric Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain., Del Mar Andrés M; Pediatric Oncology and Hematology Unit, Hospital Universitari y Politécnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain., Verdú-Amorós J; INCLIVA - Biomedical Research Institute, Hospital Clínico Universitario, Valencia, Spain., Molinés A; Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Las Palmas, Spain., Herrero B; Pediatric Oncology, Hematology and Stem Cell Transplant Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain., López M; Hematology Department, University Hospital Marqués de Valdecilla (IDIVAL), Santander, Spain., Márquez C; Department of Pediatric Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain., Toboso M; Pediatric Oncology and Hematology Unit, Hospital Universitari y Politécnic La Fe, Instituto de Investigación Sanitaria La Fe (IISLAFE), Valencia, Spain., Lendínez F; Unidad de Oncohematologia Pediatrica. Hospital Infantil Universitario Torrecárdenas, Almeria, Spain., Sirvent JG; Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain., Tallón M; Hospital Alvaro Cunqueiro, Vigo, Spain., Rodríguez G; Sofpromed, CRO para ensayos clínicos en España, Palma de Mallorca, Spain., Acha T; Unidad de Oncología Pediátrica, Hospital Materno-Infantil Carlos Haya, Málaga, Spain., Moreno L; Division of Pediatric Hematology and Oncology, Vall d'Hebron Comprehensive Cancer Center, Hospital Universitari Vall d'Hebrón, Passeig Vall d'Hebron 119, 08172, Barcelona, Spain. lucas.moreno@vallhebron.cat., Fernández-Teijeiro A; Hospital Universitario Virgen Macarena, Seville, Spain.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Sep; Vol. 26 (9), pp. 2351-2359. Date of Electronic Publication: 2024 Apr 10.
Autor:
Hidalgo-Gómez G; Hematology Service, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Unit of Biological Anthropology, Department of Animal Biology, Plant Biology, and Ecology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain., Minguela A; Immunology Service, Hospital Clínico Universitario Virgen de la Arrixaca (HCUVA), Instituto Murciano de Investigación Biomédica (IMIB), Murcia, Spain., Tazón-Vega B; Hematology Service, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain., Ribera J; Josep Carreras Leukaemia Research Institute, Hospital ICO-Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain., Galián JA; Immunology Service, Hospital Clínico Universitario Virgen de la Arrixaca (HCUVA), Instituto Murciano de Investigación Biomédica (IMIB), Murcia, Spain., Martínez-Banaclocha H; Immunology Service, Hospital Clínico Universitario Virgen de la Arrixaca (HCUVA), Instituto Murciano de Investigación Biomédica (IMIB), Murcia, Spain., García-Garay M; Immunology Service, Hospital Clínico Universitario Virgen de la Arrixaca (HCUVA), Instituto Murciano de Investigación Biomédica (IMIB), Murcia, Spain., Velasco P; Pediatric Oncology and Hematology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Fuster-Soler JL; Pediatric Onco-Hematology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain., Armengol G; Unit of Biological Anthropology, Department of Animal Biology, Plant Biology, and Ecology, Faculty of Biosciences, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain., Ortega M; Hematology Service, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Publikováno v:
British journal of haematology [Br J Haematol] 2024 Jun; Vol. 204 (6), pp. 2512-2515. Date of Electronic Publication: 2024 Apr 26.
Autor:
Velasco-Hernandez T; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain., Trincado JL; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain., Vinyoles M; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain., Closa A; The John Curtin School of Medical Research The Australian National University Canberra Australian Capital Territory Australia.; EMBL Australia Partner Laboratory Network at the Australian National University Canberra Australian Capital Territory Australia., Martínez-Moreno A; Josep Carreras Leukemia Research Institute Barcelona Spain., Gutiérrez-Agüera F; Josep Carreras Leukemia Research Institute Barcelona Spain., Molina O; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain., Rodríguez-Cortez VC; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain., Ximeno-Parpal P; Josep Carreras Leukemia Research Institute Barcelona Spain., Fernández-Fuentes N; Josep Carreras Leukemia Research Institute Barcelona Spain., Petazzi P; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain., Beneyto-Calabuig S; Centre for Genomic Regulation (CRG) The Barcelona Institute of Science and Technology Barcelona Spain.; Universitat Pompeu Fabra (UPF) Barcelona Spain., Velten L; Centre for Genomic Regulation (CRG) The Barcelona Institute of Science and Technology Barcelona Spain.; Universitat Pompeu Fabra (UPF) Barcelona Spain., Romecin P; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain., Casquero R; Josep Carreras Leukemia Research Institute Barcelona Spain., Abollo-Jiménez F; Bioinformatics Unit Maimonides Biomedical Research Institute of Córdoba (IMIBIC) Córdoba Spain., de la Guardia RD; Josep Carreras Leukemia Research Institute Barcelona Spain.; GENYO, Center for Genomics and Oncological Research Pfizer/Universidad de Granada/Junta de Andalucía Granada Spain., Lorden P; CNAG-CRG, Centre for Genomic Regulation (CRG) Barcelona Institute of Science and Technology (BIST) Barcelona Spain., Bataller A; Department of Hematology Hospital Clínic de Barcelona Barcelona Spain., Lapillonne H; Centre de Recherce Saint-Antoine Armand-Trousseau Childrens Hospital Paris France., Stam RW; Princess Maxima Center for Pediatric Oncology Utrecht The Netherlands., Vives S; Josep Carreras Leukemia Research Institute Barcelona Spain.; Hematology Department ICO-Hospital Germans Trias i Pujol Barcelona Spain., Torrebadell M; Hematology Laboratory Hospital Sant Joan de Déu Barcelona Spain.; Leukemia and Other Pediatric Hemopathies. Developmental Tumors Biology Group. Institut de Recerca Hospital Sant Joan de Déu Barcelona Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) ISCIII Madrid Spain., Fuster JL; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; Sección de Oncohematología Pediátrica Hospital Clínico Universitario Virgen de la Arrixaca and Instituto Murciano de Investigación Biosanitaria (IMIB) Murcia Spain., Bueno C; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; CIBER-ONC Barcelona Spain., Sarry JE; Centre de Recherches en Cancérologie de Toulouse Université de Toulouse Inserm U1037, CNRS U5077 Toulouse France.; LabEx Toucan Toulouse France.; Équipe Labellisée Ligue Nationale Contre le Cancer Toulouse France., Eyras E; The John Curtin School of Medical Research The Australian National University Canberra Australian Capital Territory Australia.; EMBL Australia Partner Laboratory Network at the Australian National University Canberra Australian Capital Territory Australia.; Hospital del Mar Medical Research Institute (IMIM) Barcelona Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA) Barcelona Spain., Heyn H; CNAG-CRG, Centre for Genomic Regulation (CRG) Barcelona Institute of Science and Technology (BIST) Barcelona Spain., Menéndez P; Josep Carreras Leukemia Research Institute Barcelona Spain.; Red Española de Terapias Avanzadas (TERAV)-Instituto de Salud Carlos III (ISCIII) (RICORS, RD21/0017/0029) Madrid Spain.; CIBER-ONC Barcelona Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA) Barcelona Spain.; Department of Biomedicine, School of Medicine University of Barcelona Barcelona Spain.
Publikováno v:
HemaSphere [Hemasphere] 2024 Feb 26; Vol. 8 (2), pp. e45. Date of Electronic Publication: 2024 Feb 26 (Print Publication: 2024).
Autor:
Alonso García L; Servicio de Hematología y Oncología Pediátricas, Hospital Universitari Vall d´Hebron, Barcelona, Spain., Bueno Sánchez D; Servicio de Hemato-Oncología Pediátrica, Hospital Universitario La Paz, Madrid, Spain., Fernández Navarro JM; Sección de Oncología y Hematología Infantil Hospital Universitari i Politècnic La Fe, Valencia, Spain., Regueiro Garcia A; Departamento de Hematología y Oncología Pediátricas Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain., Blanquer Blanquer M; Unidad de Trasplante Hematopoyético y Terapia Celular, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain., Benitez Carabante MI; Servicio de Hematología y Oncología Pediátricas, Hospital Universitari Vall d´Hebron, Barcelona, Spain., Mozo Del Castillo Y; Servicio de Hemato-Oncología Pediátrica, Hospital Universitario La Paz, Madrid, Spain., Fuster Soler JL; Unidad de Trasplante Hematopoyético y Terapia Celular, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain., Uria Oficialdegui ML; Servicio de Hematología y Oncología Pediátricas, Hospital Universitari Vall d´Hebron, Barcelona, Spain., Sisinni L; Servicio de Hemato-Oncología Pediátrica, Hospital Universitario La Paz, Madrid, Spain., Perez Martinez A; Servicio de Hemato-Oncología Pediátrica, Hospital Universitario La Paz, Madrid, Spain., Diaz de Heredia Rubio C; Servicio de Hematología y Oncología Pediátricas, Hospital Universitari Vall d´Hebron, Barcelona, Spain.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 Feb 01; Vol. 15, pp. 1307932. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024).
Autor:
Ramos Elbal E; Pediatric Oncohematology Department, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain., Fuster JL; Pediatric Oncohematology Department, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain., Campillo JA; Immunology Service, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain., Galera AM; Pediatric Oncohematology Department, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain., Cortés MB; Pediatric Oncohematology Department, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain., Llinares ME; Pediatric Oncohematology Department, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain., Jiménez I; Pediatric Oncohematology Department, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain., Plaza M; Pediatric Oncohematology Department, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain., Martínez Banaclocha H; Immunology Service, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain., Galián JA; Immunology Service, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain., Blanquer Blanquer M; Haematology Service, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain., Martínez Sánchez MV; Immunology Service, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain., Muro M; Immunology Service, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain., Minguela A; Immunology Service, Clinic University Hospital Virgen de la Arrixaca and Biomedical Research Institute of Murcia Pascual Parrilla (IMIB), 30120, Murcia, Spain. alfredo.minguela@carm.es.
Publikováno v:
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Jan; Vol. 26 (1), pp. 278-287. Date of Electronic Publication: 2023 Jun 27.
Autor:
Molina O; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain. omolina@carrerasresearch.org.; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain. omolina@carrerasresearch.org., Ortega-Sabater C; Mathematical Oncology Laboratory, Department of Mathematics & Institute of Applied Mathematics in Science and Engineering, Universidad de Castilla-La Mancha, Ciudad Real, Spain., Thampi N; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain., Fernández-Fuentes N; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain., Guerrero-Murillo M; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain., Martínez-Moreno A; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain., Vinyoles M; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain., Velasco-Hernández T; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain., Bueno C; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain., Trincado JL; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain.; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain., Granada I; Hematology Service, Institut Català d'Oncologia (ICO)-Hospital Germans Trias i Pujol, Badalona, Spain.; Josep Carreras Leukemia Research Institute, Autonomous University of Barcelona, Badalona, Spain., Campos D; DiNA Science, S.A, Barcelona, Spain., Giménez C; DiNA Science, S.A, Barcelona, Spain., Boer JM; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands., den Boer ML; Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology and Hematology, Erasmus Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands., Calvo GF; Mathematical Oncology Laboratory, Department of Mathematics & Institute of Applied Mathematics in Science and Engineering, Universidad de Castilla-La Mancha, Ciudad Real, Spain., Camós M; Hematology Laboratory, Hospital Sant Joan de Déu, University of Barcelona, Barcelona, Spain.; Leukemia and Other Pediatric Hemopathies, Developmental Tumor Biology Group, Institut de Recerca Hospital Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, Madrid, Spain., Fuster JL; Pediatric Hematology and Oncology Department, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain., Velasco P; Pediatric Oncology and Hematology Department, Hospital Vall d'Hebrón, Barcelona, Spain., Ballerini P; AP-HP, Service of Pediatric Hematology, Hopital Armand Trousseau, Paris, France., Locatelli F; Bambino Gesù Children's Hospital, Catholic University of Sacred Heart, Rome, Italy., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN, USA., Spierings DCJ; European Research Institute for the Biology of Aging (ERIBA), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Foijer F; European Research Institute for the Biology of Aging (ERIBA), University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Pérez-García VM; Mathematical Oncology Laboratory, Department of Mathematics & Institute of Applied Mathematics in Science and Engineering, Universidad de Castilla-La Mancha, Ciudad Real, Spain., Menéndez P; Josep Carreras Leukemia Research Institute, Department of Biomedicine, School of Medicine, University of Barcelona, Barcelona, Spain. pmenendez@carrerasresearch.org.; Red Española de Terápias Avanzadas (TERAV), Instituto de Salud Carlos III, Barcelona, Spain. pmenendez@carrerasresearch.org.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. pmenendez@carrerasresearch.org.; Department of Biomedicine. School of Medicine, University of Barcelona, Barcelona, Spain. pmenendez@carrerasresearch.org.; Spanish Cancer Research Network (CIBERONC), ISCIII, Barcelona, Spain. pmenendez@carrerasresearch.org.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2024 Jan; Vol. 16 (1), pp. 64-92. Date of Electronic Publication: 2023 Dec 15.
Autor:
Galán V; Pediatric Hemato-Oncology, La Paz University Hospital, idiPAZ Research Institute, Madrid, Spain; Pediatric Hemato-Oncology, La Paz University Hospital, Madrid, Spain., Beléndez C; Pediatric Hemato-Oncology, Hospital Gregorio Marañón, Madrid, Spain., Echecopar C; Pediatric Hemato-Oncology, La Paz University Hospital, Madrid, Spain., Estival P; Hospital Clínico de Madrid, Madrid, Spain., Sissini L; Pediatric Hemato-Oncology, La Paz University Hospital, idiPAZ Research Institute, Madrid, Spain., Olivas R; Hospital Clinico de Valencia, Valencia, Spain., Bueno D; Pediatric Hemato-Oncology, La Paz University Hospital, idiPAZ Research Institute, Madrid, Spain; Pediatric Hemato-Oncology, La Paz University Hospital, Madrid, Spain., Molina B; Pediatric Hemato-Oncology, Hospital Niño Jesus, Madrid, Spain., Fuentes C; Pediatric Hemato-Oncology, Hospital La Fe, Valencia, Spain., Regueiro A; Pediatric Hemato-Oncology, University of Santiago Clinical Hospital, Santiago de Compostela, Spain., Benítez I; Pediatric Hemato-Oncology, Hospital Vall d'Hebron, Barcelona, Spain., Plaza M; Pediatric Hemato-Oncology, Virgen de la Arrixaca University Clinical Hospital, Biomedical Research Institute of Murcia (IMIB), El Palmar, Spain., Margarit A; Pediatric Hemato-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Rifón J; Clínica Universitaria de Navarra, Pamplona, Spain., Pascual A; Pediatric Hemato-Oncology, Hospital Carlos Haya, Málaga, Spain., Palomo P; Hospital Central de Asturias, Oviedo, Spain., Urtasun A; Pediatric Hemato-Oncology, Hospital Sant Joan de Déu, Barcelona, Spain., Fuster JL; Pediatric Hemato-Oncology, Virgen de la Arrixaca University Clinical Hospital, Biomedical Research Institute of Murcia (IMIB), El Palmar, Spain., Díaz de Heredia C; Pediatric Hemato-Oncology, Hospital Vall d'Hebron, Barcelona, Spain., Fernández Navarro JM; Pediatric Hemato-Oncology, Hospital La Fe, Valencia, Spain., González-Vicent M; Pediatric Hemato-Oncology, Hospital Niño Jesus, Madrid, Spain., Ruz B; La Paz University Hospital, Institute of Medical and Molecular Genetics (INGEMM), idiPAZ Research Institute, Madrid, Spain., Pérez-Martínez A; Pediatric Hemato-Oncology, La Paz University Hospital, idiPAZ Research Institute, Madrid, Spain; Pediatric Hemato-Oncology, La Paz University Hospital, Madrid, Spain; Pediatric Hemato-Oncology, La Paz University Hospital, idiPAZ Research Institute, Pediatric Department, Autonomous University of Madrid, Madrid, Spain. Electronic address: aperezmartinez@salud.madrid.org.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Nov; Vol. 29 (11), pp. 702.e1-702.e11. Date of Electronic Publication: 2023 Aug 16.
Autor:
Quintero V; Paediatric Haeamatology and Oncology Department, La Paz University Hospital, Madrid, Spain. Electronic address: victormanuel.quintero@salud.madrid.org., Bueno-Sánchez D; Paediatric Haeamatology and Oncology Department, La Paz University Hospital, Madrid, Spain., Mozo-Del-Castillo Y; Paediatric Haeamatology and Oncology Department, La Paz University Hospital, Madrid, Spain., Urtasun-Erburu A; Paediatric Haematology and Oncology Unit, Navarra Universitary Clinic, Pamplona, Spain., Sisinni L; Paediatric Haeamatology and Oncology Department, La Paz University Hospital, Madrid, Spain., López-Duarte M; Haematology Deparment, Marqués de Valdecilla Univertsity Hospital, Santander, Spain., Pérez-Hurtado JM; Children Haematology Unit, Virgen del Rocío University Hospital, Seville, Spain., Fuster JL; Paediatric Onco/haematology, Paediatric Department, Virgen de Arrixaca University Hospital, Murcia, Spain., González-Vicent M; Onco/Haematology and transplant department, 'Niño Jesús' University Children Hospital, Madrid, Spain., Pérez-Martínez A; Paediatric Haeamatology and Oncology Department, La Paz University Hospital, Madrid, Spain., Diaz-de-Heredia C; Paediatric Haematology Oncology, Vall d´ Hebron University Hospital, Barcelona, Spain.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2023 Oct; Vol. 29 (10), pp. 621.e1-621.e6. Date of Electronic Publication: 2023 Jul 15.